Decoding Hidden Genomic Events: How Chimeric RNA Sequencing Reveals Structural Variation, Cancer Drivers, and Trait-Associated Gene Fusions

Beyond Traditional Gene Expression: Discovering the Unexpected

Most RNA sequencing studies focus on measuring which genes are turned on or off. While differential gene expression provides valuable biological insight, RNA molecules can reveal much more than expression levels alone.

Among the most informative—and often overlooked—transcripts are chimeric RNAs. These unique RNA molecules are formed when sequences from two separate genes become joined into a single transcript. Once considered rare biological anomalies, chimeric RNAs are now recognized as important regulators of development, disease, and evolution.

Advances in high-throughput RNA sequencing have transformed chimeric RNA detection into a powerful tool for identifying genomic rearrangements, uncovering disease biomarkers, and understanding the molecular basis of complex phenotypes across human, animal, and plant systems.

What Are Chimeric RNAs?

A chimeric RNA contains sequences originating from two distinct genes that are transcribed together into a single RNA molecule.

These RNA molecules are referred to as chimeric RNAs rather than gene fusions because transcripts can arise through several biological mechanisms, including:

• Chromosomal translocations that physically fuse two genes together
• Large genomic rearrangements such as inversions or deletions
• Read-through transcription between neighboring genes
• Trans-splicing, where exons from separate RNA molecules are joined together after transcription
• Complex alternative splicing events

Although many chimeric RNAs are generated through normal cellular processes, others serve as molecular signatures of genomic instability and disease.

Figure 1. Biological mechanisms underlying chimeric RNA formation, including chromosomal rearrangement, transcriptional read-through, and trans-splicing.

Importantly, not every chimeric RNA indicates an underlying DNA fusion. Distinguishing biologically meaningful fusion transcripts from normal transcriptional events requires robust sequencing data and sophisticated bioinformatics analysis.

From RNA Sequencing Reads to Fusion Discovery

Unlike DNA sequencing, RNA sequencing directly captures expressed fusion transcripts, allowing researchers to identify structural genomic events that are actively transcribed.

The chimeric RNA detection workflow includes:

High-Quality RNA Sequencing

High-quality RNA is converted into sequencing libraries and analyzed using next-generation sequencing, generating millions of paired-end reads spanning the transcriptome.

Alignment to the Reference Genome

Sequencing reads are aligned to the reference genome using splice-aware aligners capable of recognizing reads that map across two different genes.

These include:

• Split reads that span the fusion junction
• Discordant paired-end reads aligning to separate genomic locations
• Junction-spanning reads that precisely define fusion breakpoints

Figure 2. Sequencing evidence used to identify chimeric transcripts, including discordant paired-end reads and junction-spanning reads.

Fusion Detection Algorithms

Specialized software evaluates candidate fusion events by integrating multiple lines of evidence, including:

• Number of supporting junction reads
• Number of spanning fragments
• Mapping quality
• Gene orientation
• Reading frame preservation
• Distance between partner genes
• Known fusion databases and annotations

Rigorous filtering removes sequencing artifacts and false-positive predictions, producing a high-confidence list of candidate chimeric RNAs.

Connecting RNA Fusions to Genomic Rearrangements

One of the greatest strengths of chimeric RNA sequencing is its ability to reveal genomic structural variation through expressed transcripts.

When chromosomal rearrangements create new gene fusions, RNA sequencing can detect:

• Gene translocations
• Inversions
• Large deletions
• Tandem duplications
• Complex chromosomal rearrangements

Because these events are identified through expressed RNA rather than DNA alone, researchers gain insight into which structural variants are biologically active and potentially functional.

When combined with whole-genome or long-read sequencing, chimeric RNA analysis provides strong evidence linking genomic rearrangements to downstream transcriptional consequences.

Cancer Research: Discovering Oncogenic Gene Fusions

Many cancers are driven by gene fusion events that create abnormal proteins with altered biological functions.

Fusion transcripts can:

• Constitutively activate signaling pathways
• Generate novel oncogenic proteins
• Disrupt tumor suppressor genes
• Alter transcriptional regulation
• Promote drug resistance
• Serve as diagnostic and prognostic biomarkers

RNA sequencing enables researchers to identify both known and novel fusion transcripts directly from tumor samples, helping characterize tumor biology and discover actionable therapeutic targets.

Because many fusion genes are expressed only in cancer cells, they often represent highly specific biomarkers for diagnosis, patient stratification, and precision oncology.

Plant Genomics: Linking Structural Variation to Agronomic Traits

Chimeric RNAs are increasingly recognized as valuable molecular markers in agricultural research.

Structural genomic variation can generate fusion transcripts associated with traits including:

• Disease resistance
• Drought tolerance
• Heat and cold adaptation
• Flowering time
• Growth regulation
• Yield improvement
• Stress-response pathways

RNA sequencing enables plant researchers to identify expressed fusion transcripts within breeding populations, mutant lines, or diverse germplasm collections.

These discoveries help connect genomic variation with observable phenotypes, accelerating gene discovery, quantitative trait locus (QTL) interpretation, and crop improvement programs.

Applications Across Diverse Research Fields

Chimeric RNA sequencing has become an essential approach across numerous research areas beyond agricultural and cancer biology:

Clinical Genomics

It supports molecular diagnosis through expressed fusion detection and enables the investigation of disease-associated structural variants.

Functional Genomics

It enables researchers to investigate novel transcriptional mechanisms, alternative splicing, trans-splicing, and gene regulation.

Evolutionary Biology

It supports the study of genome evolution by examining how structural rearrangements generate new genes and transcripts with novel biological functions.

Transforming Fusion Discovery into Biological Insight

Chimeric RNAs provide a unique window into the dynamic relationship between genome structure and gene expression. By capturing expressed fusion transcripts, RNA sequencing uncovers biologically meaningful genomic rearrangements that may remain hidden using conventional analyses alone.

Whether identifying cancer-driving gene fusions, discovering structural variants underlying important agricultural traits, or exploring novel mechanisms of gene regulation, chimeric RNA analysis transforms transcriptome sequencing into a powerful platform for functional genomic discovery.

BMKGENE provides RNA sequencing analysis with chimeric RNA detection, revealing hidden transcript fusions that connect genome structure to biological function.